Dark Forest Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dark Forest Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$486K	Buy	+928	New	+$443K	0.04%	557
2025 Q4	–	Sell	-1,259	Closed	-$577K	–	1194
2025 Q3	$577K	Buy	+1,259	New	+$470K	0.02%	890
2025 Q1	–	Sell	-1,286	Closed	-$397K	–	1357
2024 Q4	$397K	Buy	+1,286	New	+$362K	0.06%	544
2022 Q4	–	Sell	-8	Closed	-$1K	–	1350
2022 Q3	$1K	Buy	+8	New	+$556	﹤0.01%	1058
2021 Q4	–	Sell	-17	Closed	-$1K	–	1648
2021 Q3	$1K	Buy	+17	New	+$1.47K	﹤0.01%	1200

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dark Forest Capital Management's MDGL Position: Q1 2026 in Review

Dark Forest Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q1 2026: 928 shares worth $486K. The stake represents 0.04% of the portfolio and ranks #557 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in MDGL as recently as Q3 2025.

Dark Forest Capital Management first reported a position in MDGL in Q3 2021 and has held it in 5 quarters since. The position peaked at $577K in Q3 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

Dark Forest Capital Management held 928 shares of Madrigal Pharmaceuticals worth $486K as of Q1 2026.
Madrigal Pharmaceuticals was a new Dark Forest Capital Management position in Q1 2026.
Madrigal Pharmaceuticals made up 0.04% of Dark Forest Capital Management's portfolio in Q1 2026, its #557 holding.
Dark Forest Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
Dark Forest Capital Management's Madrigal Pharmaceuticals position peaked at $577K in Q3 2025.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.